Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.15 USD
Change Today 0.00 / 0.00%
Volume 2.2K
BONE On Other Exchanges
As of 8:10 PM 10/6/15 All times are local (Market data is delayed by at least 15 minutes).

xtant medical holdings inc (BONE) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/23/14 - $4.75
52 Week Low
11/20/14 - $2.19
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

xtant medical holdings inc (BONE) Related Businessweek News

No Related Businessweek News Found

xtant medical holdings inc (BONE) Details

Xtant Medical Holdings, Inc. develops, manufactures, and markets biologics products in the United States and internationally. The company offers products for use in various applications, including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing, neurosurgery, and regeneration in knee and other joint surgeries. Its products include OsteoSponge, which provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC, a subchondral bone void filler; OsteoSelect DBM putty, an osteoinductive product used by surgeons as a bone void filler in the extremities and pelvis; and OsteoWrap that wraps around non-union fractures to assist with fusion, and could be used in conjunction with a hardware plate system. The company also provides OsteoLock and BacFast HD facet stabilization dowels used to augment spinal procedures; OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and hMatrix dermal scaffold, which promotes cellular ingrowth, tissue vascularization, and regeneration. In addition, it processes and sells sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company’s products include 3Demin cortical fibers, 3Demin boats, and 3Demin strips made from cortical bone and primarily used in spine procedures. It markets its products through direct sales force, as well as through distributor relationships. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.

148 Employees
Last Reported Date: 03/18/15

xtant medical holdings inc (BONE) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: $500.2K
Total Annual Compensation: $153.8K
Chief Financial Officer, Treasurer and Secret...
Total Annual Compensation: $350.0K
Chief Operating Officer
Total Annual Compensation: $338.6K
Chief Scientific Officer
Total Annual Compensation: $271.1K
Compensation as of Fiscal Year 2014.

xtant medical holdings inc (BONE) Key Developments

Xtant Medical Holdings, Inc. Presents at Singular Research 10th Annual "Best of the Uncovereds" Conference, Sep-17-2015

Xtant Medical Holdings, Inc. Presents at Singular Research 10th Annual "Best of the Uncovereds" Conference, Sep-17-2015 . Venue: Luxe Sunset Bel Air Hotel, 11461 Sunset Boulevard, Los Angeles, CA 90049, United States.

Xtant Medical Holdings, Inc.'s Subsidiary Bacterin International, Inc. Announces FDA Approval of OsteoSelect(R) PLUS

Xtant Medical Holdings, Inc. announced that its wholly owned subsidiary, Bacterin International, Inc., has received FDA 510(k) clearance of OsteoSelect PLUS Demineralized Bone Matrix (DBM) Putty. OsteoSelect PLUS is a next-generation DBM putty, comprised of OsteoSelect Putty with the addition of demineralized cortical chips. Aligned with the Company's commitment to patient safety, OsteoSelect PLUS will provide another Sterile grafting solution for customers. This new product will also eliminate the need to mix bone chips and DBM putty intra-operatively, saving time and reducing graft variability. With this notice and clearance from the FDA, Xtant Medical is prepared to launch OsteoSelect PLUS to customers in Fourth Quarter 2015. The company will work with its primary GPO and IDN customers to add this product to current contracts, making it available immediately upon product launch. This is the first 510(k) approval for Bacterin International since becoming a subsidiary of Xtant Medical, and will be the first of many planned product releases, as management focuses on rounding out the combined product portfolio. This new product will help drive the Company's growth and provides an opportunity for increased market share.

Xtant Medical Holdings, Inc. Presents at Rodman & Renshaw 17th Annual Global Investment Conference, Sep-09-2015 12:05 PM

Xtant Medical Holdings, Inc. Presents at Rodman & Renshaw 17th Annual Global Investment Conference, Sep-09-2015 12:05 PM. Venue: The St. Regis Hotel, Two East 55th Street, New York, NY 10022, United States. Speakers: Daniel S. Goldberger, Chief Executive Officer, David Louis Kirschman, Chief Scientific Officer, Executive Vice President and Director, John P. Gandolfo, Chief Financial Officer, Treasurer and Secretary.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BONE:US $3.15 USD 0.00

BONE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $0.34 USD +0.017
Exactech Inc $18.16 USD +0.09
RTI Surgical Inc $5.44 USD -0.29
SeaSpine Holdings Corp $15.98 USD -0.20
View Industry Companies

Industry Analysis


Industry Average

Valuation BONE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XTANT MEDICAL HOLDINGS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at